Compare Bristol-Myers Squibb Co (BMY) vs Essex Property Trust, Inc. (ESS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Essex Property Trust, Inc. — how do they compare? Bristol-Myers Squibb Co trades at $63.65 (market cap $129.94B), while Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B). The key difference: Bristol-Myers Squibb Co is far larger — about 7.2× Essex Property Trust, Inc.'s market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | ESS | |
|---|---|---|
Market Cap | $129.94B | $18.15B |
Sector | Health | Real Estate |
52-Week High | $65.89 | $298.33 |
52-Week Low | $42.60 | $239.61 |
Enterprise Value | $163.92B | $24.75B |
Dividend Yield | 3.96% | 3.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →
